Stockscreener 앱 받기
2.24
0.00%
0.00
전일 마감가:
$2.24
열려 있는:
$2.22
하루 거래량:
13,256
Relative Volume:
0.20
시가총액:
$73.75M
수익:
$48.66M
순이익/손실:
$4.52M
주가수익비율:
16.06
EPS:
0.1395
순현금흐름:
$5.72M
1주 성능:
+1.82%
1개월 성능:
-3.45%
6개월 성능:
-21.40%
1년 성능:
-17.95%
1일 변동 폭
$2.18
$2.23
1주일 범위
$2.18
$2.3299
52주 변동 폭
$2.00
$4.12
Research Solutions Inc Stock (RSSS) Company Profile
명칭
Research Solutions Inc
전화
310 477 0354
주소
10624 S. EASTERN AVE, HENDERSON, CA
Compare RSSS vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 2.35 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.69 | 2.64B | 0 | 0 | 0 | 0.00 |
GOODO
Gladstone Commercial Corporation
|
20.59 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.36 | 375.29M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
4.07 | 281.75M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
47.93 | 0 | 0 | 0 | 0 | 0.00 |
Research Solutions Inc 주식(RSSS)의 최신 뉴스
Research Solutions Inc (RSSS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Research Solutions Inc (RSSS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Research Solutions Inc (RSSS) Balance Sheet - TradingKey
Research Solutions Inc (RSSS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
RSSS|Research Solutions Inc|Price:2.205|Chg%:+0.005 - TradingKey
Research Solutions Inc (RSSS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Research Solutions Inc (RSSS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
RSSS|Research Solutions Inc|Price:2.210|Chg%:+0.010 - TradingKey
RSSS|Research Solutions Inc|Price:2.200| - TradingKey
Research Solutions Inc (RSSS) Holds Steady at $2.20 as Key Support and Resistance Levels Define Trading RangeVolume Spike Alerts - dars.gov.et
Research Solutions, Inc. Revenue Breakdown – SWB:61I - TradingView
Research Solutions Inc (RSSS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enterprise value to EBITDA forward of Research Solutions, Inc – NASDAQ:RSSS - TradingView
Financial Crime And Fraud Management Solutions Market Research Reveals Path To $40.95 Billion By 2030 - openPR.com
Price to book forward of Research Solutions, Inc – NASDAQ:RSSS - TradingView
Price to sales forward of Research Solutions, Inc – NASDAQ:RSSS - TradingView
Water Tower Research Publishes Initiation of Coverage Report on Maison Solutions, Inc., "Putting the "AI" in Maison: A Leaner Store Base Meets a Smarter Grocery Platform" - The Globe and Mail
Price to earnings forward of Research Solutions, Inc – NASDAQ:RSSS - TradingView
Enterprise value to EBITDA forward of Research Solutions, Inc. – SWB:61I - TradingView
Agilent Strengthens Biopharma Growth Prospects With AI Expansion - TradingView
Price to earnings forward of Research Solutions, Inc. – SWB:61I - TradingView
RSSS stock holds the focus on Research Solutions' data work - Ad-hoc-news.de
Price to sales forward of Research Solutions, Inc. – SWB:61I - TradingView
Price to earnings forward of Research Solutions, Inc. – LSX:A1JSMK - TradingView
Tekton Research and Summit Clinical Research Solutions Expand Partnership, Bring MASH Trials to Ohio - GlobeNewswire
Research Solutions stock leans on its platform model - Ad-hoc-news.de
Research Solutions Inc (RSSS) Q2 2026 Earnings: EPS Misses Estimates, Shares Slide 4%Diluted EPS Report - dars.gov.et
Form DEF 14A Research Solutions Inc For: 2 July By Investing.com - Investing.com Canada
Enterprise value to EBIT forward of Research Solutions, Inc – NASDAQ:RSSS - TradingView
AMR Clinical Acquires ClinOhio Research Services - Morningstar
Enterprise value to revenue forward of Research Solutions, Inc – NASDAQ:RSSS - TradingView
Research Solutions (RSSS) Stock Sees Fair Value Cut As Analysts Flag Revenue And Churn - Yahoo Finance
Enterprise value to EBIT forward of Majestic Research Services & Solutions Ltd. – BSE:MRSS - TradingView
Research Solutions, Inc. Actuals & Estimates (NASDAQ:RSSS) - TradingView
RSSS Forecast — Price Target — Prediction for 2027 - TradingView
Trusted Title Search Launches Innovative Online Platform for Florida Title Searches and Property Research - Digital Journal
Research Solutions Inc (RSSS) Q1 2026 Earnings: EPS Misses Estimates, Revenue Not DisclosedEarnings Cycle Report - dars.gov.et
Research Solutions (RSSS) Holds Steady at $2.25 as Traders Await CatalystPairs Trade - DonanımHaber
Research Solutions StockThursday technical picture and trading levels - AD HOC NEWS
Research Solutions Inc (RSSS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Research Solutions Inc (RSSS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Research Solutions Inc (RSSS) Institutional Confidence - TradingKey
Research Solutions Inc (RSSS) Gains 3.6% as Momentum Builds Near Key ResistanceMomentum Factor - newsline.com
RSSS Q1 2026 Earnings: EPS Misses Estimates Amid Positive Stock ReactionRevenue Guidance Range - newsline.com
Research Solutions (RSSS) 16th Annual East Coast IDEAS Conference Summary - Quartr
RSSS: AI-powered research access and citation tools drive scalable growth and margin expansion - TradingView
Anthropic pledges $200 million to research AI's economic impact as CEO suggests job loss solutions - Yahoo Finance
RSSS Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock ReactionEPS Surprise History - newsline.com
Element Biosciences Announces Upsized Series E to Accelerate Global Growth Across Ecosystem of Genomic, Multiomic, and Clinical Research Solutions - Business Wire
Research Solutions Inc (RSSS) Gains 2.2% as Stock Approaches Key ResistanceGap Up Stocks - newsline.com
Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution - PR Newswire
Research Solutions Inc (RSSS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Research Solutions Inc 주식 (RSSS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Regazzi John J | Director |
Nov 17 '25 |
Option Exercise |
0.70 |
150,000 |
105,000 |
318,500 |
1.15%
5.57%
자본화:
|
볼륨(24시간):